Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation
- PMID: 30006596
- PMCID: PMC6045614
- DOI: 10.1038/s41467-018-05118-3
Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation
Abstract
Liposomes have been well established as an effective drug delivery system, due to simplicity of their preparation and unique characteristics. However conventional liposomes are unsuitable for the on-demand content release, which limits their therapeutic utility. Here we report X-ray-triggerable liposomes incorporating gold nanoparticles and photosensitizer verteporfin. The 6 MeV X-ray radiation induces verteporfin to produce singlet oxygen, which destabilises the liposomal membrane and causes the release of cargos from the liposomal cavity. This triggering strategy is demonstrated by the efficiency of gene silencing in vitro and increased effectiveness of chemotherapy in vivo. Our work indicates the feasibility of a combinatorial treatment and possible synergistic effects in the course of standard radiotherapy combined with chemotherapy delivered via X-ray-triggered liposomes. Importantly, our X-ray-mediated liposome release strategy offers prospects for deep tissue photodynamic therapy, by removing its depth limitation.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Light-triggered liposomal cargo delivery platform incorporating photosensitizers and gold nanoparticles for enhanced singlet oxygen generation and increased cytotoxicity.Int J Nanomedicine. 2017 Feb 2;12:969-977. doi: 10.2147/IJN.S126553. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28203076 Free PMC article.
-
X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs.Int J Nanomedicine. 2018 Jun 19;13:3553-3570. doi: 10.2147/IJN.S164967. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29950835 Free PMC article.
-
Tumor pH-triggered "charge conversion" nanocarriers with on-demand drug release for precise cancer therapy.J Mater Chem B. 2020 Oct 21;8(40):9351-9361. doi: 10.1039/d0tb01692f. J Mater Chem B. 2020. PMID: 32996552
-
Glutathione-triggered drug release from nanostructures.Curr Top Med Chem. 2014;14(23):2662-71. doi: 10.2174/1568026614666141215143659. Curr Top Med Chem. 2014. PMID: 25515752 Review.
-
Liposomal nanostructures for photosensitizer delivery.Lasers Surg Med. 2011 Sep;43(7):734-48. doi: 10.1002/lsm.21101. Lasers Surg Med. 2011. PMID: 22057501 Review.
Cited by
-
A Snapshot of Photoresponsive Liposomes in Cancer Chemotherapy and Immunotherapy: Opportunities and Challenges.ACS Omega. 2023 Nov 14;8(47):44424-44436. doi: 10.1021/acsomega.3c04134. eCollection 2023 Nov 28. ACS Omega. 2023. PMID: 38046305 Free PMC article. Review.
-
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.Mol Cancer. 2023 Oct 3;22(1):160. doi: 10.1186/s12943-023-01849-0. Mol Cancer. 2023. PMID: 37784179 Free PMC article. Review.
-
Nature vs. Manmade: Comparing Exosomes and Liposomes for Traumatic Brain Injury.AAPS J. 2023 Aug 23;25(5):83. doi: 10.1208/s12248-023-00849-8. AAPS J. 2023. PMID: 37610471 Review.
-
Engineered inhaled nanocatalytic therapy for ischemic cerebrovascular disease by inducing autophagy of abnormal mitochondria.NPJ Regen Med. 2023 Aug 11;8(1):44. doi: 10.1038/s41536-023-00315-1. NPJ Regen Med. 2023. PMID: 37567914 Free PMC article.
-
Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications.Life (Basel). 2023 Mar 29;13(4):903. doi: 10.3390/life13040903. Life (Basel). 2023. PMID: 37109432 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
